Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding.
Min Taek LeeKwang Yeol ParkMyo-Song KimSeung-Hun YouYe-Jin KangSun-Young JungPublished in: Yonsei medical journal (2020)
When NSAIDs or SSRIs are required for NOAC users with AF, physicians need to monitor bleeding events and consider the use of PPIs, especially for combined use of both drugs or when initiating NOACs treatment.